dactinomycin and Gestational Trophoblastic Disease

dactinomycin has been researched along with Gestational Trophoblastic Disease in 152 studies

Research

Studies (152)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.66)	18.7374
1990's	0 (0.00)	18.2507
2000's	41 (26.97)	29.6817
2010's	78 (51.32)	24.3611
2020's	32 (21.05)	2.80

Authors

Authors	Studies
Guo, T; Luo, Y; Xiao, P; Yin, R; Zhang, M	1
An, R; Hao, J; Xue, Y; Yu, H; Zhang, M; Zhang, T; Zhou, W	1
Jareemit, N; Kuljarusnont, S; Phianpiset, R; Ruengkhachorn, I; Udompunturak, S	1
Feng, F; Ji, M; Jiang, S; Ren, T; Wan, X; Xiang, Y; Yang, J; Zhao, J	1
Kiu, DKL; Lim, YN; Loo, KCY; Sim, WW	1
Berkowitz, RS; Bianconi, MI; Cortés-Charry, R; Elias, KM; Horowitz, NS; Jankilevich, G; Maestá, I; Mejía, CRV; Otero, S; Ramírez, LAC; Seckl, M	1
Cushen, BF; Hancock, BW; Hills, A; Kandiah, K; Palmer, JE; Parker, VL; Singh, K; Tidy, JA; Winter, MC	1
Albright, BB; Davidson, BA; Ellett, T; Goins, EC; Havrilesky, LJ; Kaplan, SJ; Knochenhauer, HE; Monuszko, KA; Moss, HA; Previs, RA	1
Berkowitz, RS; Braga, A; Elias, KM; Freitas, F; Fülöp, V; Horowitz, NS; Jareemit, N; Maestá, I; Paiva, G; Ramírez, LAC; Therasakvichya, S	1
Jiang, J; Li, H; Shi, B; Sun, M; Wang, B; Wang, L; Wang, W; Wu, W	1
Gillett, S; Hapuarachi, B; Ireson, J; Romanowski, C; Singh, K; Tidy, JA; Winter, MC	1
Cang, W; Feng, F; Qiu, L; Ren, T; Wan, X; Xiang, Y; Xue, W; Yang, J; Zhao, J	1
Aguiar, X; Sarwar, N; Seckl, MJ; Singh, K; Tidy, JA; Winter, MC	1
Balthar, E; Berkowitz, RS; Braga, A; Elias, KM; Filho, JR; Horowitz, NS; Junior, JA; Madi, JM; Rech, M; Samora, M; Souza, LCS; Sun, SY	1
Feng, FZ; Guan, CL; Jiang, F; Jiao, LZ; Lu, X; Mao, MY; Ren, T; Wan, XR; Xiang, Y; Yang, JJ; Zhao, J	1
Baloch, SS; Khan, SR; Moosajee, M; Samon, Z; Shahid, A; Shahzadi, M; Tariq, M	1
Ino, K; Kajiyama, H; Kikkawa, F; Kotani, T; Niimi, K; Nishino, K; Sato, S; Suzuki, S; Yamamoto, E	1
Berkowitz, RS; Desmarais, CCF; Elias, KM; Goldstein, DP; Horowitz, NS; Maestá, I; Nitecki, R	1
Hoeijmakers, YM; Lok, C; Ottevanger, PB; Sweep, F	1
Hoskins, PJ; Kim, H; Kumar, A; Le, N; Osborne, RJ; Pina, A; Sabourin, JN	1
Tai, YJ	1
Berkowitz, RS; Elias, KM; Goldstein, DP; Horowitz, NS; Jareemit, N	1
Anderson, N; Carter, J; Filiaci, V; Horowitz, N; Huang, HQ; Kushnir, C; Miller, DS; Moxley, K; Schink, JC; Taylor, SE; Tidy, J; Winter, M; Yabuno, A	1
Alves-Ferreira, M; Bin, S; Bolze, PA; Devouassoux-Shisheboran, M; Freyer, G; Gladieff, L; Golfier, F; Grazziotin-Soares, D; Hajri, T; Joly, F; Langlois-Jacques, C; Lotz, JP; Massardier, J; Maucort-Boulch, D; Mercier, C; Rousset, P; Roux, A; Villeneuve, L; You, B	1
Coleman, RE; Gillett, S; Hancock, BW; Hills, A; Ireson, J; Singh, K; Tidy, JA; Winter, MC	2
Chen, Y; Wang, K	1
Winter, MC	1
Aguiar, X; Cortés-Charry, R; Froeling, FEM; Harvey, R; Hennah, L; Kaur, B; Sarwar, N; Savage, P; Seckl, MJ; Short, D; Tin, T; Unsworth, N	1
Braga, A; Mattar, R; Passos, JP; Signorini Filho, RC; Silva, ACBD; Sun, SY	1
Allias Montmayeur, F; Bolze, PA; Descargues, P; Devouassoux-Shisheboran, M; Golfier, F; Hajri, T; Lotz, JP; Massardier, J; You, B	1
Chen, L; Chen, Y; Cheng, X; Hu, D; Jiang, J; Kong, B; Li, Q; Li, X; Liu, X; Lu, W; Ma, D; Mao, Y; Pan, Z; Ping, Q; Qu, P; Wan, X; Wang, X; Weng, D; Xi, L; Xie, X; Yin, R; Zhang, H; Zhang, X	1
Feng, F; Kong, Y; Li, Y; Ren, T; Wan, X; Xiang, Y; Yang, J; Zhao, J	1
Baartz, D; Garrett, AJ; Morrison, S; Sanday, K; Verhoef, L	1
Eysbouts, YK; IntHout, J; Lok, CAR; Massuger, LFAG; Ottevanger, PB; Sweep, FCGJ	1
Feng, F; Jiang, F; Kong, Y; Li, J; Ren, T; Wan, X; Wang, X; Xiang, Y; Yang, J; Zhao, J	1
Brown, J; Bruegl, A; Essel, KG; Gershenson, DM; Naumann, RW; Ramondetta, LM	1
Chen, H; Fang, F; Fu, J; He, F; Hu, L; Lawrie, TA; Wang, Q; Wu, T; Xie, L	1
Li, J; Li, S; Lu, X; Wang, J; Xu, C; Yu, H	1
Anca, AF; Bacalbasa, N; Balescu, I; Brasoveanu, V	1
Bergamini, A; Candiani, M; Cioffi, R; Cormio, G; Gadducci, A; Giorgione, V; Mangili, G; Pella, F; Petrone, M; Rabaiotti, E	1
Gong, FQ; Niu, G; Shen, HW; Yang, J; Yuan, LJ; Zhu, CX	1
Bolze, PA; Devouassoux, M; Golfier, F; Hajri, T; Lotz, JP; Massardier, J; Patrier, S; Prouvot, C; Schott, AM; You, B	1
Li, Q; Mu, X; Song, L; Wang, D; Yin, R; Zhao, X	1
Altman, AD; Carlson, V; Dean, E; Lambert, P; Lotocki, R; Walters, L	1
Harada, N; Haruta, N; Higashiura, Y; Hisanaga, H; Nobuhara, I; Sado, T; Watanabe, H; Watanabe, S	1
Li, Q; Ma, Y; Mu, X; Song, L; Wang, D; Yin, R; Zhao, X	1
Bolze, PA; Dabi, Y; Golfier, F; Hajri, T; Khawajkie, Y; Lotz, JP; Massardier, J; Mathé, M; Patrier, S; Schott, AM; You, B	1
Coleman, RE; Hancock, BW; Macdonald, MC; Tidy, JA; Winter, MC	1
Coulter, J; Frijstein, MM; Golfier, F; Lok, CAR; Massuger, LFAG; Seckl, MJ; Ten Kate-Booij, MJ; van Trommel, NE	1
Berkowitz, RS; Braga, A; Dos Santos Esteves, APV; Elias, KM; Filho, JR; Horowitz, NS; Mora, PAR; Sun, SY; Uberti, EH; Velarde, GC	1
de Melo, AC; Paulino, E	1
Duan, W; Kang, HL; Yang, SL; Zhao, Q	1
Deng, L; Lawrie, TA; Wu, T; Zhang, J	1
Benigno, BB	1
Bajpai, J; Deodhar, K; Gulia, S; Gupta, S; Kerkar, RA; Maheshwari, A; Menon, S; Rekhi, B; Seth, V	1
Augereau, P; Balleyguier, C; Droz, JP; Duvillard, P; Even, C; Fizazi, K; Floquet, A; Kerbrat, P; Leary, A; Lhommé, C; Morice, P; Pautier, P; Rey, A; Tazi, Y; Troalen, F	1
Anfinan, N; Sait, H; Sait, K	1
Feng, FZ; Ren, T; Wan, XR; Wang, T; Xiang, Y	1
Ahmad, S; Ahmed, M; Al-Badawi, IA; Al-Hashem, H; Al-Hayli, S; Al-Husaini, H; Darwish, A; Edesa, W; Elghamry, W; Elhassan, T; Eltigani, A; Madkhali, I; Omar, A; Soudy, H	1
Gilani, MM; Khorasanizadeh, F; Mousavi, AS; Zamani, A; Zendehdel, K	1
Camarata, M; Cooke, R; Dancy, G; Krell, J; Kwan, A; O'Nions, J; Savage, P; Seckl, MJ; Short, D; Swerdlow, A	1
Kelpanides, I; Savage, P; Seckl, MJ; Short, D; Tuthill, M	1
Chan, KK; Chu, MM; Ma, Y; Ngan, HY; Tse, KY	1
Berkowitz, RS; Bernstein, MR; Goldstein, DP; Horowitz, NS; Maestá, I; Moulder, J; Ramírez, LA	1
Feng, F; Ren, T; Wan, X; Xiang, Y; Xiao, C; Yang, J; Zhao, J	1
Berkowitz, RS; Bernstein, MR; Goldstein, DP; Horowitz, NS; Maestá, I; Ramírez, LA	1
Faaborg, L; Hansen, ES; Lindegaard, JC; Niemann, I; Ostenfeld, EB; Sunde, L	1
Boonyapipat, S; Rattanaburi, A; Supasinth, Y	1
Ayub, AC; Braga, A; da Cunha, AG; Fajardo, Mdo C; Frota, SS; Uberti, EM	1
Abdi, S; Coleman, RE; Hancock, BW; Lo, C; Price, JM; Tidy, J; Winter, MC	1
Deng, W; Hénin, E; Osborne, R; Oza, A; You, B	1
Deng, Y; Ding, H; Ding, Y; Fan, H; Hu, Y; Lai, W; Peng, M; Tao, G; Wu, X; Wu, Y; Yu, L; Zhang, H	1
Bae, SN; Byun, SW; Park, TC	1
Abbaslu, F; Adabi, K; Aminimoghaddam, S; Hanjani, P; Mousavi, A; Nekuie, S; Yarandi, F	1
Duan, W; Kong, WM; Miao, JW; Su, L; Wang, T; Wang, Y; Wu, YM	1
Nevado-Gammad, MS; Soriano-Estrella, AL	1
Alazzam, M; Hancock, BW; Lawrie, TA; Osborne, R; Tidy, J	2
Cosio, S; Fanucchi, A; Gadducci, A; Manacorda, S; Pistolesi, S; Strigini, FL; Tana, R	1
Feng, F; Ren, T; Wan, X; Xiang, Y; Yang, J	1
Basaran, D; Karalok, A; Kimyon, GC; Tasci, T; Tulunay, G; Turan, T; Turkmen, O; Ureyen, I	1
Berkowitz, RS; Braga, A; Burlá, M; Elias, KM; Lin, L; Madi, JM; Maestá, I; Sun, SY; Torres, B; Uberti, E; Viggiano, M	1
Barnett, JC; Chappell, NP; Havrilesky, LJ; Leath, CA; Miller, CR; Phippen, NT; Sledge, C	1
Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, YJ; Nam, JH; Park, JY; Suh, DS	1
Eftekhar, Z; Hanjani, P; Kanani, S; Sharifi, A; Shojaei, H; Yarandi, F	1
Berkowitz, RS; Fülöp, V; Szepesi, J; Szigetvŕi, I; Török, M	1
Behnamfar, F; Mousavi, SA	1
Cao, Y; Feng, FZ; Li, L; Wan, XR; Xiang, Y; Yang, XY	1
Belfort, P; Braga, A; Consonni, M; Delmanto, LR; Maestá, I; Michelin, OC; Rudge, MV	1
Anderson, ML; Beasley, AD; Coleman, NM; Kolomeyevskaya, NV; Miller, HJ; Tanyi, JL	1
Alazzam, M; Hancock, BW; Osborne, R; Tidy, J	1
Deng, L; Wu, T; Yan, X; Zhang, J	1
Ayub, AC; da Cunha, AG; Fajardo, Mdo C; Graudenz, Mda S; Rosa, MW; Schmid, H; Uberti, EM	1
Cao, Y; Feng, F; Wan, X; Xiang, Y; Yang, X	1
Israngura, N; Lertkhachonsuk, AA; Tangtrakul, S; Wilailak, S	1
Cao, Y; Feng, F; Xiang, Y	1
Cho, YL; Choi, MH; Hong, DG; Lee, YS; Park, IS	1
Lurain, JR	1
Cho, HY; Cho, MK; Choi, HS; Kang, WD; Kim, CH; Kim, JW; Kim, SM; Kim, YH	1
Feng, F; Geng, S; Wan, X; Wang, T; Xiang, Y	1
Aghajanian, C	1
Alvarez Secord, A; Covens, AL; Filiaci, V; Kelley, JL; Lage, JM; Mannel, RS; Osborne, RJ; Provencher, D; Schink, JC; Scott Miller, D	1
Harvey, R; Mitchell, H; Savage, P; Schmid, P; Seckl, M; White, S	1
Feng, FZ; Geng, S; Wan, XR; Xiang, Y; Zhou, Y	1
Cyriac, S; Rajendranath, R; Sagar, TG; Sridevi, V	1
Cheraghi, F; Gilani, MM; Mousavi, A; Shojaei, H; Yarandi, F	1
Capstick, V; Eiriksson, L; Hoskins, P; Pike, J; Schepansky, A; Steed, H; Swenerton, K; Wells, T	1
Langmár, Z; Németh, M	1
Cole, LA	1
Aydiner, A; Bengisu, E; Berkman, S; Ilhan, HR; Keskin, S; Tas, F; Topuz, E	1
Chapman-Davis, E; Hoekstra, AV; Lurain, JR; Rademaker, AW; Schink, JC	1
Manopunya, M; Suprasert, P	1
Amant, F; Devi, UK; Han, SN; Leunen, K; Neven, P; Vergote, I	1
Dodge, J; Osborne, R	1
Lybol, C; Massuger, LFAG; Ottevanger, PB; Sweep, FCGJ; Thomas, CMG; Westerdijk, K	1
Baptista, AM; Belfort, P	1
Centen, DW; Lybol, C; Massuger, LF; Ottevanger, PB; Sweep, FC; ten Kate-Booij, MJ; Thomas, CM; Verheijen, RH	1
Chen, H; Fang, F; Fu, J; He, F; Hu, L; Lawrie, TA; Wu, T; Xie, L	1
Blanken, EA; Boere, IA; Lybol, C; Massuger, LF; Ottevanger, PB; Reyners, AK; Sweep, FC; Thomas, CM; van Hoesel, RQ; Verheijen, RH; Westermann, AM	1
Agarwal, R; Alifrangis, C; Fisher, RA; Harvey, R; Savage, PM; Sebire, NJ; Seckl, MJ; Short, D	1
Goto, M; Hirokawa, W; Iwase, A; Kikkawa, F; Kondo, M; Nakahara, T; Nakamura, T; Sugita, A; Takikawa, S; Yamamoto, E	1
Iitsuka, Y; Matsui, H; Seki, K; Sekiya, S; Suzuka, K; Tanaka, N; Yamazawa, K	1
Li, J; Wan, XR; Wu, Y; Xiang, Y; Yang, XY; Yang, YM; Yin, SJ	1
BREWER, JI; DOLKART, RE; GERBIE, AB; NAGLE, RG; SKOM, JH; TOROK, EE	1
Bozorgi, K; Escobar, PF; Fishman, DA; Lurain, JR; Singh, DK	1
Behtash, N; Ghaemmaghami, F; Hanjani, P; Soleimani, K	1
Bethan Powell, C; Chen, LM; Lengyel, ER	1
Iitsuka, Y; Matsui, H; Mitsuhashi, A; Sekiya, S; Suzuka, K; Yamazawa, K	1
Sun, Z; Wan, X; Xiang, Y; Yang, X	1
Gerulath, A; Osborne, R	1
Matsui, H; Mitsuhashi, A; Seki, K; Sekiya, S; Suzuka, K; Tanaka, N; Yamazawa, K	1
Eftekhar, Z; Gilani, MM; Hanjani, P; Yarandi, F	1
Sun, ZJ; Wan, XR; Xiang, Y; Yang, XY	1
Qian, JH; Xie, X; Ye, DF	1
Lurain, JR; Nejad, B	1
De Nápoli, G; Diestel, MC; Guimarães, FE; Schmid, H; Uberti, EM	1
Chen, L; Dong, RF; Liu, N; Wan, XR; Wu, Y; Xiang, Y; Yang, XY	1
Wan, X; Xiang, Y; Yang, J; Yang, X	1
An, RF; Wu, TX; Xue, Y; Zhang, J	1
Burger, RA; Chen, MD; Covens, A; Filiaci, VL; Osborne, R	1
Lurain, JR; Schink, JC; Singh, DK	2
Cagayan, MS; Lu-Lasala, LR	1
Clarke-Pearson, DL; Kirkpatrick, JP; Sampson, JH; Soper, JT; Spillman, M; Wolf, JK	1
Wan, XR; Xiang, Y; Yang, JJ; Yang, XY	1
Lv, W; Mao, Y; Wan, X; Xie, X	1
El-Helw, LM; Hancock, BW	1
Abrão, RA; Candido dos Reis, FJ; Clagnan, WS; de Andrade, JM; Marana, HR; Tiezzi, DG	1
Chen, L; Dong, R; Liu, N; Wan, X; Wu, Y; Xiang, Y; Yang, X	1
Ashrafgangooei, T; Azamolsadat, M; Behroozi, S; Behtash, N; Fatemeh, G; Ghaemmaghami, F; Ghanbari, Z; Gilani, MM; Mitra, MG; Mousavi, A; Nadereh, B; Shohreh, B; Tahereh, A; Zinat, G	1
Holden, L; McNeish, I; Newlands, ES; Rustin, GJ; Seckl, MJ; Strickland, S	1

Reviews

23 review(s) available for dactinomycin and Gestational Trophoblastic Disease

Article	Year
Real-world data of 14 cases of brain metastases from gestational trophoblastic neoplasia and a literature review. Archives of gynecology and obstetrics, 2022, Volume: 305, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies	2022
Direct comparisons of efficacy and safety between actinomycin-D and methotrexate in women with low-risk gestational trophoblastic neoplasia: a meta-analysis of randomized and high-quality non-randomized studies. BMC cancer, 2021, Oct-18, Volume: 21, Issue:1 Topics: Alopecia; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Chemical and Drug Induced Liver Injury; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Nausea; Pregnancy; Randomized Controlled Trials as Topic; Remission Induction; Risk; Treatment Outcome; Vomiting	2021
Treatments and outcomes in high-risk gestational trophoblastic neoplasia: A systematic review and meta-analysis. BJOG : an international journal of obstetrics and gynaecology, 2023, Volume: 130, Issue:5 Topics: Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies	2023
Gestational trophoblastic neoplasia with primary lung cancer and mesenchymal tumor of sigmoid colon: a case report and literature review. BMC women's health, 2023, 02-20, Volume: 23, Issue:1 Topics: Colon, Sigmoid; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Pregnancy; Retrospective Studies	2023
Leptomeningeal disease as a presenting feature of gestational trophoblastic neoplasia: A review and recommendations for management. Gynecologic oncology, 2023, Volume: 172 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Paclitaxel; Placenta; Pregnancy; Quality of Life; Retrospective Studies; Vincristine	2023
Immunotherapy in the treatment of chemoresistant gestational trophoblastic neoplasia - systematic review with a presentation of the first 4 Brazilian cases. Clinics (Sao Paulo, Brazil), 2023, Volume: 78 Topics: Brazil; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Immunotherapy; Methotrexate; Pregnancy; Retrospective Studies	2023
Review of current literature on gestational trophoblastic neoplasia. Journal of the Egyptian National Cancer Institute, 2023, Nov-27, Volume: 35, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies; Vincristine	2023
Treatment of low-risk gestational trophoblastic neoplasia. Best practice & research. Clinical obstetrics & gynaecology, 2021, Volume: 74 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies	2021
Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. The Cochrane database of systematic reviews, 2017, 09-11, Volume: 9 Topics: Antineoplastic Agents; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Incidence; Methotrexate; Pregnancy; Randomized Controlled Trials as Topic	2017
The efficacy and safety of first-line single-agent chemotherapy regimens in low-risk gestational trophoblastic neoplasia: A network meta-analysis. Gynecologic oncology, 2018, Volume: 148, Issue:2 Topics: Antineoplastic Agents; Dactinomycin; Drug Administration Schedule; Female; Folic Acid; Gestational Trophoblastic Disease; Humans; Infusions, Intravenous; Injections, Intramuscular; Methotrexate; Nausea; Pregnancy; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Vomiting	2018
Early pregnancy following multidrug regimen chemotherapy in a gestational trophoblastic neoplasia patient: A case report. Medicine, 2017, Volume: 96, Issue:51 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Dactinomycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fetal Development; Fluorouracil; Gestational Age; Gestational Trophoblastic Disease; Humans; Infant Health; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prenatal Care; Term Birth	2017
Multiple metastatic gestational trophoblastic disease after a twin pregnancy with complete hydatidiform mole and coexisting fetus, following assisted reproductive technology: Case report and literature review. Taiwanese journal of obstetrics & gynecology, 2018, Volume: 57, Issue:4 Topics: Abortion, Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fertilization in Vitro; Gestational Age; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Hysterectomy; Lung Neoplasms; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, Twin; Tomography, X-Ray Computed; Uterine Hemorrhage; Uterine Neoplasms; Vincristine	2018
Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour. The Cochrane database of systematic reviews, 2013, Jan-31, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Doxorubicin; Early Termination of Clinical Trials; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Hydroxyurea; Leucovorin; Melphalan; Methotrexate; Pregnancy; Trophoblastic Tumor, Placental Site; Vincristine	2013
First-line chemotherapy in low-risk gestational trophoblastic neoplasia. The Cochrane database of systematic reviews, 2016, Jun-09, Issue:6 Topics: Antineoplastic Agents; Case-Control Studies; Cohort Studies; Dactinomycin; Drug Administration Schedule; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Pregnancy; Randomized Controlled Trials as Topic; Risk; Vitamin B Complex	2016
First line chemotherapy in low risk gestational trophoblastic neoplasia. The Cochrane database of systematic reviews, 2009, Jan-21, Issue:1 Topics: Antineoplastic Agents; Case-Control Studies; Cohort Studies; Dactinomycin; Drug Administration Schedule; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Pregnancy; Randomized Controlled Trials as Topic; Risk; Vitamin B Complex	2009
Combination chemotherapy for high-risk gestational trophoblastic tumour. The Cochrane database of systematic reviews, 2009, Apr-15, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Hydroxyurea; Melphalan; Methotrexate; Pregnancy; Trophoblastic Tumor, Placental Site; Vincristine	2009
Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. American journal of obstetrics and gynecology, 2011, Volume: 204, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin; Dactinomycin; Drug Administration Schedule; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Leucovorin; Methotrexate; Neoplasm Staging; Pregnancy; Remission Induction; Treatment Failure	2011
First-line chemotherapy in low-risk gestational trophoblastic neoplasia. The Cochrane database of systematic reviews, 2012, Jul-11, Issue:7 Topics: Antineoplastic Agents; Case-Control Studies; Cohort Studies; Dactinomycin; Drug Administration Schedule; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Pregnancy; Randomized Controlled Trials as Topic; Risk; Vitamin B Complex	2012
Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. The Cochrane database of systematic reviews, 2012, Oct-17, Volume: 10 Topics: Antineoplastic Agents; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Methotrexate; Pregnancy; Randomized Controlled Trials as Topic	2012
What is the best regimen for low-risk gestational trophoblastic neoplasia? A review. The Journal of reproductive medicine, 2004, Volume: 49, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dactinomycin; Drug Administration Schedule; Female; Gestational Trophoblastic Disease; Humans; Prognosis	2004
Secondary chemotherapy for high-risk gestational trophoblastic neoplasia. Gynecologic oncology, 2005, Volume: 97, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Treatment Outcome; Vincristine	2005
Combination chemotherapy for high-risk gestational trophoblastic tumour. The Cochrane database of systematic reviews, 2006, Jul-19, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Hydroxyurea; Leucovorin; Methotrexate; Pregnancy; Trophoblastic Tumor, Placental Site; Vincristine	2006
Treatment of metastatic gestational trophoblastic neoplasia. The Lancet. Oncology, 2007, Volume: 8, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Vincristine	2007

Trials

22 trial(s) available for dactinomycin and Gestational Trophoblastic Disease

Article	Year
Efficacies of FAEV and EMA/CO regimens as primary treatment for gestational trophoblastic neoplasia. British journal of cancer, 2022, Volume: 127, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Neoplasm Recurrence, Local; Pregnancy; Vincristine	2022
Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0-4): study protocol for a prospective, multicentre, randomized trial. BMC cancer, 2023, Aug-23, Volume: 23, Issue:1 Topics: Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Multicenter Studies as Topic; Pregnancy; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic	2023
The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia. International journal of clinical oncology, 2020, Volume: 25, Issue:1 Topics: Adolescent; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leukopenia; Menstrual Cycle; Methotrexate; Middle Aged; Nausea; Pregnancy; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Young Adult	2020
An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275. Gynecologic oncology, 2020, Volume: 158, Issue:2 Topics: Dactinomycin; Drug Administration Schedule; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Patient Reported Outcome Measures; Pregnancy; Quality of Life	2020
Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020, 09-20, Volume: 38, Issue:27 Topics: Adult; Antibiotics, Antineoplastic; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Chorionic Gonadotropin; Dactinomycin; Drug Resistance, Neoplasm; Fatigue; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Injection Site Reaction; Methotrexate; Middle Aged; Nausea; Pregnancy; Retreatment; Vomiting; Young Adult	2020
Chemotherapy initiation with single-course methotrexate alone or combined with dactinomycin versus multi-course methotrexate for low-risk gestational trophoblastic neoplasia: a multi-centric randomized clinical trial. Frontiers of medicine, 2022, Volume: 16, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies	2022
Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group-174 Phase III Trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2016, Volume: 26, Issue:1 Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Chorionic Gonadotropin; Dactinomycin; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Models, Statistical; Neoplasm Staging; Predictive Value of Tests; Pregnancy; Prognosis; Young Adult	2016
Five-Day Intravascular Methotrexate Versus Biweekly Actinomycin-D in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia: A Clinical Randomized Trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2016, Volume: 26, Issue:5 Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Dactinomycin; Drug Administration Schedule; Female; Gestational Trophoblastic Disease; Humans; Injections, Intramuscular; Injections, Intravenous; Methotrexate; Pregnancy; Prospective Studies	2016
Pulse methotrexate versus pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2008, Volume: 103, Issue:1 Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Injections, Intramuscular; Injections, Intravenous; Methotrexate; Pregnancy; Pulse Therapy, Drug; Remission Induction; Risk; Treatment Failure; Young Adult	2008
Actinomycin d versus methotrexate-folinic acid as the treatment of stage I, low-risk gestational trophoblastic neoplasia: a randomized controlled trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Lung Neoplasms; Maximum Tolerated Dose; Methotrexate; Neoplasm Staging; Pregnancy; Prognosis; Survival Rate; Treatment Outcome; Vitamin B Complex	2009
Treatment of low-risk gestational trophoblastic neoplasia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Mar-01, Volume: 29, Issue:7 Topics: Choriocarcinoma; Dactinomycin; Drug Administration Schedule; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Staging; Pregnancy; Pulse Therapy, Drug; Risk Assessment; Treatment Outcome	2011
Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Mar-01, Volume: 29, Issue:7 Topics: Adult; Biopsy, Needle; Choriocarcinoma; Dactinomycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Immunohistochemistry; Injections, Intramuscular; Injections, Intravenous; Logistic Models; Maximum Tolerated Dose; Medical Oncology; Methotrexate; Neoplasm Staging; Odds Ratio; Ontario; Pregnancy; Pulse Therapy, Drug; Treatment Outcome; Young Adult	2011
Comparison of pulsed actinomycin D versus 5-day methotrexate for the treatment of low-risk gestational trophoblastic disease. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2012, Volume: 116, Issue:1 Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Dactinomycin; Drug Administration Schedule; Female; Gestational Trophoblastic Disease; Humans; Infusions, Intravenous; Injections, Intramuscular; Methotrexate; Neoplasm Staging; Pregnancy; Treatment Outcome	2012
Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy. Gynecologic oncology, 2003, Volume: 91, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Prospective Studies; Risk Factors; Vincristine	2003
Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia. Gynecologic oncology, 2004, Volume: 94, Issue:1 Topics: Adult; Antibiotics, Antineoplastic; Dactinomycin; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Risk Factors	2004
Salvage chemotherapy for high-risk gestational trophoblastic tumor. The Journal of reproductive medicine, 2004, Volume: 49, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Middle Aged; Risk Factors; Salvage Therapy; Treatment Outcome	2004
EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor. The Journal of reproductive medicine, 2004, Volume: 49, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Treatment Outcome	2004
Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy. Gynecologic oncology, 2005, Volume: 96, Issue:3 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Infusions, Intravenous; Injections, Intramuscular; Leucovorin; Methotrexate; Recurrence; Remission Induction; Risk Factors; Treatment Outcome	2005
Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia. The Australian & New Zealand journal of obstetrics & gynaecology, 2005, Volume: 45, Issue:2 Topics: Adolescent; Adult; Antineoplastic Agents; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Infusions, Intravenous; Injections, Intramuscular; Methotrexate; Pregnancy; Pulse Therapy, Drug; Treatment Outcome	2005
Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study. Cancer, 2006, Sep-15, Volume: 107, Issue:6 Topics: Adult; Antibiotics, Antineoplastic; Chorionic Gonadotropin; Dactinomycin; Drug Administration Schedule; Female; Gestational Trophoblastic Disease; Humans; Injections, Intravenous; Nausea; Neutropenia; Pregnancy; Pulse Therapy, Drug; Risk Factors; Salvage Therapy; Treatment Outcome; Vomiting	2006
Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2007, Volume: 98, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cisplatin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine	2007
Efficacy of the FAEV regimen in the treatment of high-risk, drug-resistant gestational trophoblastic tumor. The Journal of reproductive medicine, 2007, Volume: 52, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Treatment Outcome; Vincristine	2007

Other Studies

107 other study(ies) available for dactinomycin and Gestational Trophoblastic Disease

Article	Year
Predictive factors associated with resistance to initial methotrexate treatment in women with low-risk gestational trophoblastic neoplasia. Asia-Pacific journal of clinical oncology, 2022, Volume: 18, Issue:5 Topics: Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies	2022
Gestational trophoblastic neoplasm in a patient with end-stage renal failure (ESRF): the challenges and lessons learnt. BMJ case reports, 2022, May-18, Volume: 15, Issue:5 Topics: Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Hysterectomy; Kidney Failure, Chronic; Pregnancy; Retrospective Studies; Uterine Neoplasms	2022
Clinical Presentation, Treatment Outcomes, and Resistance-related Factors in South American Women with Low-risk Postmolar Gestational Trophoblastic Neoplasia. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2022, Volume: 44, Issue:8 Topics: Brazil; Cohort Studies; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies; Risk Factors; Treatment Outcome	2022
Flat-dose versus weight or body surface area-based methotrexate dosing in low-risk gestational trophoblastic neoplasia. Gynecologic oncology, 2023, Volume: 169 Topics: Body Surface Area; Dactinomycin; Drug-Related Side Effects and Adverse Reactions; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies	2023
EMACO for treatment of gestational trophoblastic neoplasia: A multinational multicenter study. Gynecologic oncology, 2023, Volume: 170 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies; Vincristine	2023
Effect of actinomycin D on ovarian reserve in low-risk gestational trophoblastic neoplasia. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2023, 08-07, Volume: 33, Issue:8 Topics: Anti-Mullerian Hormone; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Ovarian Reserve; Pregnancy; Pregnancy Outcome	2023
Efficacy analysis of single-agent carboplatin AUC4 2-weekly as second-line therapy for methotrexate-resistant (MTX-R) low risk gestational trophoblastic neoplasia (GTN). Gynecologic oncology, 2023, Volume: 175 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies	2023
Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia. Gynecologic oncology, 2020, Volume: 157, Issue:2 Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Cohort Studies; Dactinomycin; Drug Resistance, Neoplasm; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Young Adult	2020
Risk factors for second-line dactinomycin failure after methotrexate treatment for low-risk gestational trophoblastic neoplasia: a retrospective study. BJOG : an international journal of obstetrics and gynaecology, 2020, Volume: 127, Issue:9 Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Chorionic Gonadotropin; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Retreatment; Retrospective Studies; Risk Factors; Treatment Failure; Young Adult	2020
Single or two drug combination therapy as initial treatment for low risk, gestational trophoblastic neoplasia. A Canadian analysis. Gynecologic oncology, 2020, Volume: 157, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Canada; Chorionic Gonadotropin; Cohort Studies; Dactinomycin; Drug Administration Schedule; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Retrospective Studies; Risk Factors; Young Adult	2020
A switch to dactinomycin: what is the cutoff value for hCG? BJOG : an international journal of obstetrics and gynaecology, 2020, Volume: 127, Issue:9 Topics: Chorionic Gonadotropin; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies; Risk Factors	2020
EMA vs EMACO in the treatment of gestational trophoblastic neoplasia. Gynecologic oncology, 2020, Volume: 158, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dactinomycin; Doxorubicin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Mitoxantrone; Multivariate Analysis; Neoplasm Staging; Pregnancy; Retrospective Studies; Vincristine	2020
M-EA (methotrexate, etoposide, dactinomycin) and EMA-CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first-line treatment of high-risk gestational trophoblastic neoplasia. International journal of cancer, 2021, 05-01, Volume: 148, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Risk Factors; Vincristine	2021
Management and prognostic analysis of patients with gestational trophoblastic neoplasia (GTN) in FIGO stage IV and its special type. Clinical & experimental metastasis, 2021, Volume: 38, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Disease Management; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Survival Rate; Vincristine	2021
Increasing the human chorionic gonadotrophin cut-off to ≤1000 IU/l for starting actinomycin D in post-molar gestational trophoblastic neoplasia developing resistance to methotrexate spares more women multi-agent chemotherapy. ESMO open, 2021, Volume: 6, Issue:3 Topics: Chorionic Gonadotropin; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Pregnancy	2021
Uterine Rescue in High-Risk Gestational Trophoblastic Neoplasia Treated with EMA-CO by Uterine Arteries Embolization due to Arteriovenous Malformations. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2021, Volume: 43, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Arteriovenous Malformations; Cyclophosphamide; Dactinomycin; Embolization, Therapeutic; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Pregnancy, High-Risk; Ultrasonography, Prenatal; Uterine Artery; Uterine Hemorrhage; Vincristine; Young Adult	2021
Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France. American journal of obstetrics and gynecology, 2021, Volume: 225, Issue:4 Topics: Adolescent; Adult; Aftercare; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; France; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Hysterectomy; Leucovorin; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine; Young Adult	2021
Results with Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational Trophoblastic Neoplasias with International Federation of Gynecology and Obstetrics Scores ≥5. The oncologist, 2021, Volume: 26, Issue:12 Topics: Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Obstetrics; Pregnancy; Vincristine	2021
Outcomes of women diagnosed and treated for low-risk gestational trophoblastic neoplasia at the Queensland Trophoblast Centre (QTC). The Australian & New Zealand journal of obstetrics & gynaecology, 2017, Volume: 57, Issue:4 Topics: Adolescent; Adult; Antineoplastic Agents; Dactinomycin; Disease-Free Survival; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Queensland; Remission Induction; Retrospective Studies; Risk; Treatment Outcome; Uterine Neoplasms; Young Adult	2017
The added value of hysterectomy in the management of gestational trophoblastic neoplasia. Gynecologic oncology, 2017, Volume: 145, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Treatment Outcome; Vincristine; Young Adult	2017
Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study. Gynecologic oncology, 2017, Volume: 146, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Prognosis; Retrospective Studies; Risk Factors; Salvage Therapy; Vincristine; Young Adult	2017
Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility? Gynecologic oncology, 2017, Volume: 146, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Kaplan-Meier Estimate; Medical Futility; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk Factors; Salvage Therapy; Vincristine; Young Adult	2017
Debulking Surgery for Pelvic Recurrence After Surgically-treated Tubal Gestational Choriocarcinoma - A Case Report and Literature Review. Anticancer research, 2018, Volume: 38, Issue:1 Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Choriocarcinoma; Cytoreduction Surgical Procedures; Dactinomycin; Fallopian Tube Neoplasms; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, Ectopic; Salpingectomy; Young Adult	2018
Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy: Retrospective Analysis From the MITO-9 Group. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2018, Volume: 28, Issue:2 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Infant, Newborn; Italy; Male; Methotrexate; Multicenter Studies as Topic; Pregnancy; Pregnancy Outcome; Retrospective Studies; Vincristine; Young Adult	2018
Efficacy and Safety of Second-Line 5-Day Dactinomycin in Case of Methotrexate Failure for Gestational Trophoblastic Neoplasia. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2018, Volume: 28, Issue:5 Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies; Treatment Failure	2018
Comparison of pulsed actinomycin D and 5-day actinomycin D as first-line chemotherapy for low-risk gestational trophoblastic neoplasia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2018, Volume: 143, Issue:2 Topics: Adult; Antibiotics, Antineoplastic; China; Dactinomycin; Drug Administration Schedule; Female; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult	2018
Low-Risk Gestational Trophoblastic Neoplasia in Manitoba: Experience With Alternating Methotrexate and Dactinomycin. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2018, Volume: 28, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Manitoba; Methotrexate; Pregnancy; Retrospective Studies; Risk Factors	2018
Hepatic toxicity following actinomycin D chemotherapy in treatment of familial gestational trophoblastic neoplasia: A case report. Medicine, 2018, Volume: 97, Issue:38 Topics: Adaptor Proteins, Signal Transducing; Administration, Intravenous; Antibiotics, Antineoplastic; Asian People; Chemical and Drug Induced Liver Injury; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Drug-Related Side Effects and Adverse Reactions; Female; Gestational Trophoblastic Disease; Humans; Hypolipidemic Agents; Liver; Lung Neoplasms; Mutation; Neoplasm Staging; Phosphatidylcholines; Pregnancy; Proteins; Saponins; Tomography, X-Ray Computed; Treatment Outcome; Triterpenes; Young Adult	2018
Outcome of First-Line Hysterectomy for Gestational Trophoblastic Neoplasia in Patients No Longer Wishing to Conceive and Considered With Isolated Lung Metastases: A Series of 30 Patients. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2018, Volume: 28, Issue:9 Topics: Adult; Cohort Studies; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Lung Neoplasms; Methotrexate; Middle Aged; Predictive Value of Tests; Pregnancy; Retrospective Studies; Salvage Therapy; Treatment Outcome	2018
Management and Outcomes of Patients with Stage I and IlIl Low-Risk Gestational Trophoblastic Neoplasia Treated in Sheffield, UK, from 1997-2006. The Journal of reproductive medicine, 2016, Volume: 61, Issue:7-8 Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Remission Induction; Retrospective Studies	2016
Is there uniformity in definitions and treatment of gestational trophoblastic disease in Europe? International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2019, Volume: 29, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Europe; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Vincristine	2019
Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia? Gynecologic oncology, 2019, Volume: 153, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brazil; Carboplatin; Dactinomycin; Drug Resistance, Neoplasm; Drug Substitution; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies; Treatment Outcome; Young Adult	2019
Actinomycin D shortage in the Brazilian market: new challenges for successful treatment of gestational trophoblastic neoplasia. Journal of gynecologic oncology, 2019, Volume: 30, Issue:4 Topics: Antibiotics, Antineoplastic; Brazil; Dactinomycin; Drug Industry; Female; Gestational Trophoblastic Disease; Humans; Pregnancy	2019
Efficacy of Combination Therapy with Actinomycin D and Methotrexate in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia. Chemotherapy, 2019, Volume: 64, Issue:1 Topics: Adult; Antimetabolites, Antineoplastic; Chorionic Gonadotropin; Dactinomycin; Drug Therapy, Combination; Female; Gestational Trophoblastic Disease; Hematologic Diseases; Humans; Logistic Models; Methotrexate; Middle Aged; Neoplasm Staging; Oral Ulcer; Pregnancy; Prognosis; Treatment Outcome; Young Adult	2019
High-dose chemotherapy with autologous stem cell support as salvage therapy in recurrent gestational trophoblastic disease. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2013, Volume: 23, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Pregnancy; Prognosis; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Vincristine	2013
Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India. Clinical oncology (Royal College of Radiologists (Great Britain)), 2014, Volume: 26, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; India; Methotrexate; Middle Aged; Pregnancy; Salvage Therapy; Survival Analysis; Tertiary Care Centers; Treatment Outcome; Vincristine; Young Adult	2014
Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia. European journal of cancer (Oxford, England : 1990), 2014, Volume: 50, Issue:12 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Remission Induction; Survival Analysis; Young Adult	2014
Gestational trophoblastic disease in the western region of Saudi Arabia (single-institute experience). European journal of obstetrics, gynecology, and reproductive biology, 2014, Volume: 180 Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Choriocarcinoma; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Lung Neoplasms; Methotrexate; Middle Aged; Pregnancy; Prevalence; Prognosis; Saudi Arabia; Uterine Neoplasms; Young Adult	2014
Combination chemotherapy regimen with floxuridine, dactinomycin, etoposide, and vincristine as primary treatment for gestational trophoblastic neoplasia. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2014, Volume: 36, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Retrospective Studies; Treatment Outcome; Vincristine; Young Adult	2014
Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2015, Volume: 17, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Choriocarcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Remission Induction; Retrospective Studies; Risk Factors; Salvage Therapy; Survival Rate; Uterine Neoplasms; Vaginal Neoplasms; Vincristine; Young Adult	2015
Resistance to single-agent chemotherapy and its risk factors in low-risk gestational trophoblastic neoplasms. The journal of obstetrics and gynaecology research, 2015, Volume: 41, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Iran; Methotrexate; Middle Aged; Pregnancy; Risk Factors; Vincristine; Young Adult	2015
Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Feb-10, Volume: 33, Issue:5 Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Incidence; Kaplan-Meier Estimate; Menopause, Premature; Methotrexate; Middle Aged; Neoplasms, Second Primary; Odds Ratio; Pregnancy; Risk Assessment; Risk Factors; Uterine Neoplasms; Vincristine; Young Adult	2015
Brain metastases in gestational trophoblast neoplasia: an update on incidence, management and outcome. Gynecologic oncology, 2015, Volume: 137, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma, Non-gestational; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Methotrexate; Middle Aged; Pregnancy; Treatment Outcome; Vincristine; Young Adult	2015
Cyclophosphamide, hydroxyurea, actinomycin D, methotrexate, and vincristine in the treatment of gestational trophoblastic neoplasia. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Hydroxyurea; Methotrexate; Neoplasm Recurrence, Local; Neutropenia; Pregnancy; Retrospective Studies; Salvage Therapy; Stomatitis; Survival Rate; Treatment Outcome; Vincristine; Vomiting	2015
Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Obesity; Overweight; Pregnancy; Prognosis; Remission Induction; Vincristine; Young Adult	2015
Management and prognosis of patients with brain metastasis from gestational trophoblastic neoplasia: a 24-year experience in Peking union medical college hospital. BMC cancer, 2015, Apr-28, Volume: 15 Topics: Adult; Brain Neoplasms; China; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Risk Factors; Vincristine	2015
Relationship between race and clinical characteristics, extent of disease, and response to chemotherapy in patients with low-risk gestational trophoblastic neoplasia. Gynecologic oncology, 2015, Volume: 138, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asian; Black or African American; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Risk Factors; White People; Young Adult	2015
A 30-year experience in using oral methotrexate as initial treatment for gestational trophoblastic neoplasia regardless of risk group. Acta oncologica (Stockholm, Sweden), 2016, Volume: 55, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Risk Factors; Treatment Outcome; Vincristine; Young Adult	2016
Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia. Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:12 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Nomograms; Pregnancy; Prognosis; Regression Analysis; ROC Curve; Vincristine; Young Adult	2015
Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day Methotrexate with folinic acid versus bolus-dose Actinomycin-D, among Brazilian women. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2015, Volume: 37, Issue:6 Topics: Adolescent; Adult; Antineoplastic Agents; Brazil; Dactinomycin; Drug Administration Schedule; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk Assessment; Young Adult	2015
The Role of Computed Tomography Scanning of the Thorax in the Initial Assessment of Gestational Trophoblastic Neoplasia. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:9 Topics: Administration, Intravenous; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Neoplasm Staging; Pregnancy; Radiography, Thoracic; Risk Assessment; Salvage Therapy; Tomography, X-Ray Computed	2015
Tegafur Substitution for 5-Fu in Combination with Actinomycin D to Treat Gestational Trophoblastic Neoplasm. PloS one, 2015, Volume: 10, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Pregnancy; Tegafur	2015
Conservative Chemotherapy in Gestational Trophoblastic Disease: Experience With Etoposide, Methotrexate, and Dactinomycin Chemotherapy. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2016, Volume: 26, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Pregnancy; Prognosis; Salvage Therapy	2016
Comparison of MACT and 5Fu+ACT-D chemotherapy regimens in the treatment of low-risk gestational trophoblastic neoplasia. Journal of chemotherapy (Florence, Italy), 2016, Volume: 28, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk; Treatment Outcome; Young Adult	2016
Etoposide-Actinomycin as Salvage Regimen for the Treatment of Nonmetastatic and Low-Risk Metastatic Gestational Trophoblastic Neoplasia: Experience at the Philippine General Hospital. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2016, Volume: 26, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Pregnancy; Retrospective Studies; Risk Factors; Salvage Therapy	2016
Prognosis of Patients with Gestational Trophoblastic Neoplasia and Obstetric Outcomes of Those Conceiving After Chemotherapy. Anticancer research, 2016, Volume: 36, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Etoposide; Female; Fertility Preservation; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Middle Aged; Pregnancy; Prognosis; Term Birth; Treatment Outcome; Uterine Neoplasms; Young Adult	2016
Primary treatment of stage IV gestational trophoblastic neoplasia with floxuridine, dactinomycin, etoposide and vincristine (FAEV): A report based on our 10-year clinical experiences. Gynecologic oncology, 2016, Volume: 143, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Neoplasm Staging; Pregnancy; Vincristine	2016
Factors related to treatment outcomes in low-risk gestational neoplasia. Tumori, 2017, Mar-24, Volume: 103, Issue:2 Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Middle Aged; Pregnancy; Prognosis; Retrospective Studies; Treatment Outcome; Young Adult	2017
Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation? Gynecologic oncology, 2016, Volume: 143, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brazil; Case-Control Studies; Chemotherapy, Adjuvant; Chorionic Gonadotropin; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Leucovorin; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Vacuum Curettage; Vincristine; Watchful Waiting; Young Adult	2016
Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia. Gynecologic oncology, 2016, Volume: 143, Issue:3 Topics: Adult; Antineoplastic Agents; Carboplatin; Chorionic Gonadotropin; Dactinomycin; Drug Resistance, Neoplasm; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm, Residual; Pregnancy; Retrospective Studies; Risk Assessment; Risk Factors; Uterine Neoplasms; Young Adult	2016
Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174? Gynecologic oncology, 2017, Volume: 144, Issue:1 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Dactinomycin; Decision Trees; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Quality of Life; Randomized Controlled Trials as Topic; Retreatment	2017
Comparing and evaluating the efficacy of methotrexate and actinomycin D as first-line single chemotherapy agents in low risk gestational trophoblastic disease. Journal of gynecologic oncology, 2017, Volume: 28, Issue:2 Topics: Adult; Antineoplastic Agents; Dactinomycin; Drug Administration Schedule; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Retrospective Studies	2017
Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary. The Journal of reproductive medicine, 2008, Volume: 53, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hungary; Hysterectomy; Methotrexate; Middle Aged; Pregnancy; Risk Factors; Vincristine; Young Adult	2008
Gestational trophoblastic tumor with liver metastasis after misoprostol abortion. Archives of gynecology and obstetrics, 2009, Volume: 279, Issue:4 Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Liver Neoplasms; Methotrexate; Misoprostol; Pregnancy; Uterine Neoplasms; Vincristine	2009
[Efficacy of surgical management combined with chemotherapy in the treatment of drug-resistant gestational trophoblastic neoplasm]. Zhonghua fu chan ke za zhi, 2008, Volume: 43, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Hysterectomy; Lung Neoplasms; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Young Adult	2008
Maternal and perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia in Brazilian women. Gynecologic oncology, 2009, Volume: 112, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Brazil; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hydroxyurea; Methotrexate; Pregnancy; Pregnancy Outcome; Retrospective Studies; Risk Factors; Vincristine	2009
Balloon tamponade of hemorrhage after uterine curettage for gestational trophoblastic disease. Obstetrics and gynecology, 2009, Volume: 113, Issue:2 Pt 2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Balloon Occlusion; Catheterization; Dactinomycin; Dilatation and Curettage; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Pregnancy; Uterine Hemorrhage	2009
Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up Gynecologic oncology, 2009, Volume: 114, Issue:2 Topics: Adult; Antibiotics, Antineoplastic; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Pregnancy; Retrospective Studies	2009
Surgical resection in the management of pulmonary metastatic disease of gestational trophoblastic neoplasia. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Vincristine; Young Adult	2009
Metastasis of gestational trophoblastic neoplasia to the spinal canal: a case report. The Journal of reproductive medicine, 2009, Volume: 54, Issue:9 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Etoposide; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Magnetic Resonance Imaging; Methotrexate; Pregnancy; Spinal Canal; Spinal Neoplasms; Uterine Neoplasms; Vincristine; Young Adult	2009
A case of uterine pseudoaneurysm combined with gestational trophoblastic disease in a 30-year-old woman. Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy, 2011, Volume: 20, Issue:1 Topics: Adult; Aneurysm, False; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Dilatation and Curettage; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Trophoblastic Neoplasms; Ultrasonography, Doppler; Uterine Artery; Uterine Artery Embolization; Vincristine	2011
Serum hCG level and rising world health organization score at second-line chemotherapy (pulse dactinomycin): poor prognostic factors for methotrexate-failed low-risk gestational trophoblastic neoplasia. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2010, Volume: 20, Issue:8 Topics: Adult; Antibiotics, Antineoplastic; Biomarkers, Pharmacological; Biomarkers, Tumor; Chemotherapy, Adjuvant; Chorionic Gonadotropin; Dactinomycin; Diagnostic Techniques, Obstetrical and Gynecological; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Prognosis; Pulse Therapy, Drug; Research Design; Retrospective Studies; Risk Factors; Treatment Failure; Up-Regulation; World Health Organization; Young Adult	2010
Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia. Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult	2011
Characterisation of transient benign hCG elevations in women following chemotherapy for GTT. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2011, Volume: 31, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Estradiol; Etoposide; Female; Follicle Stimulating Hormone; Gestational Trophoblastic Disease; Humans; Ifosfamide; Leucovorin; Luteinizing Hormone; Methotrexate; Pregnancy; Retrospective Studies; Taxoids; Vincristine; Young Adult	2011
[Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole]. Zhonghua fu chan ke za zhi, 2011, Volume: 46, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Methotrexate; Pregnancy; Retrospective Studies; Risk Factors; Treatment Outcome; Uterine Neoplasms	2011
Etoposide, cisplatin-etoposide, methotrexate, actinomycin-D as primary treatment for management of very-high-risk gestational trophoblastic neoplasia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2011, Volume: 115, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Disease Progression; Etoposide; Female; Gestational Trophoblastic Disease; Humans; India; Liver Neoplasms; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult	2011
Combined methotrexate-dactinomycin: an effective therapy for low-risk gestational trophoblastic neoplasia. Gynecologic oncology, 2012, Volume: 124, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult	2012
[Gestational trophoblastic neoplasia]. Orvosi hetilap, 2011, Dec-04, Volume: 152, Issue:49 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Hysterectomy; Methotrexate; Neoplasm Staging; Pregnancy; Risk Assessment; Risk Factors	2011
Minimally-aggressive gestational trophoblastic neoplasms. Gynecologic oncology, 2012, Volume: 125, Issue:1 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Treatment Outcome; Vincristine	2012
The roles of surgery and EMA/CO chemotherapy regimen in primary refractory and non-refractory gestational trophoblastic neoplasia. Journal of cancer research and clinical oncology, 2012, Volume: 138, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Half-Life; Humans; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Uterine Neoplasms; Vincristine; Young Adult	2012
Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy. Gynecologic oncology, 2012, Volume: 125, Issue:3 Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dactinomycin; Drug Resistance, Neoplasm; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Risk Factors; Young Adult	2012
Resistant gestational trophoblastic neoplasia patients treated with 5-fluorouracil plus actinomycin D. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Dactinomycin; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Prognosis; Salvage Therapy	2012
EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2012, Volume: 22, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Prognosis; Retrospective Studies; Uterine Neoplasms; Young Adult	2012
Gestational trophoblastic neoplasia. Obstetrics and gynecology clinics of North America, 2012, Volume: 39, Issue:2 Topics: Antimetabolites, Antineoplastic; Biomarkers, Tumor; Choriocarcinoma; Chorionic Gonadotropin; Dactinomycin; Female; Gene Expression Regulation, Neoplastic; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Methotrexate; Neoplasm Staging; Pregnancy; Prognosis; Severity of Illness Index; Uterine Neoplasms	2012
Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Vincristine	2012
Comparison of methotrexate, actinomycin D, and etoposide for treating low-risk gestational trophoblastic neoplasia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2012, Volume: 119, Issue:1 Topics: Adult; Alopecia; Antineoplastic Agents; Chorionic Gonadotropin; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leucovorin; Methotrexate; Nausea; Pregnancy; Prospective Studies; Remission Induction; Stomatitis; Vitamin B Complex; Vomiting; Young Adult	2012
Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study. BJOG : an international journal of obstetrics and gynaecology, 2012, Volume: 119, Issue:12 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Choriocarcinoma; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Guideline Adherence; Humans; Hydatidiform Mole; Hysterectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Netherlands; Practice Guidelines as Topic; Pregnancy; Retrospective Studies; Risk Assessment; Treatment Outcome; Uterine Neoplasms; Vincristine	2012
Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia. European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Netherlands; Pregnancy; Prognosis; Remission Induction; Risk Factors; Survival Rate; Vincristine	2013
EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jan-10, Volume: 31, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Remission Induction; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine	2013
Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia. European journal of obstetrics, gynecology, and reproductive biology, 2013, Volume: 167, Issue:2 Topics: Adult; Anti-Mullerian Hormone; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Dactinomycin; Dilatation and Curettage; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Methotrexate; Ovary; Pregnancy; Young Adult	2013
Risk of abnormal pregnancy completing chemotherapy for gestational trophoblastic tumor. Gynecologic oncology, 2003, Volume: 88, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Pregnancy Outcome; Remission Induction; Time Factors	2003
[Floxuridine-containing regime in the treatment of gestational trophoblastic tumor]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2003, Volume: 25, Issue:4 Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Dactinomycin; Drug Administration Schedule; Female; Floxuridine; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole, Invasive; Middle Aged; Pregnancy; Uterine Neoplasms; Vincristine	2003
CHEMOTHERAPY IN TROPHOBLASTIC DISEASES. American journal of obstetrics and gynecology, 1964, Nov-01, Volume: 90 Topics: Chlorambucil; Choriocarcinoma; Chorionic Gonadotropin; Dactinomycin; Drug Therapy; Female; Gestational Trophoblastic Disease; Gonadotropins; Humans; Hydatidiform Mole, Invasive; Hysterectomy; Methotrexate; Neoplasm Metastasis; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms	1964
Management of patients with metastatic gestational trophoblastic tumor. Gynecologic oncology, 2004, Volume: 94, Issue:1 Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Risk Factors	2004
[Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour]. Zhonghua fu chan ke za zhi, 2005, Volume: 40, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dactinomycin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leukopenia; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Treatment Outcome; Trophoblastic Tumor, Placental Site; Uterine Neoplasms	2005
[Clinical analysis of 13 cases of gestational trophoblastic tumor misdiagnosed as ectopic pregnancy]. Zhonghua fu chan ke za zhi, 2005, Volume: 40, Issue:2 Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Diagnostic Errors; Drug Administration Schedule; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole, Invasive; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Pregnancy, Ectopic; Retrospective Studies; Uterine Neoplasms	2005
Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole. Gynecologic oncology, 2006, Volume: 102, Issue:2 Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Cohort Studies; Dactinomycin; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Pregnancy; Reproduction; Retrospective Studies	2006
[Efficacy of FAEV regimen in treatment of high-risk drug-resistant gestational trophoblastic tumor]. Zhonghua fu chan ke za zhi, 2006, Volume: 41, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Middle Aged; Neoplasm Staging; Pregnancy; Treatment Outcome; Vincristine	2006
Recurrent gestational trophoblastic tumor: management and risk factors for recurrence. Gynecologic oncology, 2006, Volume: 103, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Dactinomycin; Etoposide; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Retrospective Studies; Risk Factors; Vincristine	2006
Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. The Journal of reproductive medicine, 2006, Volume: 51, Issue:10 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Illinois; Medical Records; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Retrospective Studies; Survival Analysis; Treatment Outcome; Uterine Neoplasms; Vincristine	2006
Role of surgery in the management of high-risk gestational trophoblastic neoplasia. The Journal of reproductive medicine, 2006, Volume: 51, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Hysterectomy; Illinois; Medical Records; Methotrexate; Middle Aged; Pregnancy; Retrospective Studies; Survival Analysis; Uterine Neoplasms; Vincristine	2006
Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital. The Journal of reproductive medicine, 2006, Volume: 51, Issue:10 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Injections, Spinal; Medical Records; Methotrexate; Middle Aged; Neoplasm Metastasis; Philippines; Pregnancy; Retrospective Studies; Survival Analysis; Uterine Neoplasms; Vincristine	2006
High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients. Gynecologic oncology, 2007, Volume: 104, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Craniotomy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Staging; Pregnancy; Radiosurgery; Risk Factors; Vincristine	2007
[Management and prognosis in stage IV gestational trophoblastic neoplasia patients]. Zhonghua fu chan ke za zhi, 2006, Volume: 41, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Female; Fluorouracil; Gestational Trophoblastic Disease; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Prognosis; Retrospective Studies; Treatment Outcome	2006
Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens. Gynecologic oncology, 2008, Volume: 108, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Risk Factors	2008
Assessment of the response to chemotherapy in gestational trophoblastic neoplasia with vaginal metastases. Archives of gynecology and obstetrics, 2008, Volume: 278, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Retrospective Studies; Survival Analysis; Vaginal Neoplasms; Vincristine; Young Adult	2008
Management of brain metastases in patients with high-risk gestational trophoblastic tumors. The Journal of reproductive medicine, 2002, Volume: 47, Issue:6 Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cause of Death; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Prognosis; Remission Induction; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine	2002